A.M. Best Affirms Credit Ratings of Hanwha General Insurance Company Limited

HONG KONG–(BUSINESS WIRE)–A.M. Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” of Hanwha General Insurance Company Limited (HGI) (South Korea). The outlook of these Credit Ratings (ratings) is stable.

The ratings reflect HGI’s adequate risk-adjusted capitalization and recent improvement in its operating results. In addition, the ratings incorporate the implicit and explicit support the company receives from its parent company, Hanwha Life Insurance Co., Ltd.

HGI’s risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR), decreased in 2016 due to an increase in investment and underwriting risks that was stronger than the growth of capital and surplus. The company reported strong growth in net premium income in 2016, driven by increases in premium rates and retention in its major business line of long-term insurance. However, the current ratings are supported by factors that include HGI’s proactive capital management strategies and conservative investment portfolio. Moreover, the company reported considerable improvement in profitability over the past three years, owing to measures such as restructuring its insurance portfolio and increases in premium rates.

Partially offsetting rating factors include the company’s increased reliance on reinsurance arrangements for its long-term insurance business line and its high asset leverage, which could cause volatility in profitability and capitalization. Positive rating actions could occur if HGI demonstrates a stable track record in operating performance and capitalization. Negative rating actions could occur if the company’s operating performance or risk-adjusted capitalization deteriorates significantly, or if there is a sizeable decline in the parent company’s financial strength and credit profile.

Ratings are communicated to rated entities prior to publication. Unless stated otherwise, the ratings were not amended subsequent to that communication.

This press release relates to Credit Ratings that have been published on A.M. Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see A.M. Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Understanding Best’s Credit Ratings. For information on the proper media use of Best’s Credit Ratings and A.M. Best press releases, please view Guide for Media – Proper Use of Best’s Credit Ratings and A.M. Best Rating Action Press Releases.

A.M. Best is the world’s oldest and most authoritative insurance rating and information source. For more information, visit www.ambest.com.

Copyright © 2017 by A.M. Best Rating Services, Inc. and/or its subsidiaries. ALL RIGHTS RESERVED.

Nexterday North 2017 Re-Invents the Core of the Digital and Communications Industry

HELSINKI–(BUSINESS WIRE)–Comptel Corporation, now a Nokia company, today unveiled the scope of its third annual Nexterday North “anti-seminar,” taking place 19-21 September 2017 in Helsinki, Finland.

For the last two years, Nexterday North has gathered thought leaders in the digital and communications services industry to outline a plan for re-invention and determine how to execute it, with the goal of motivating innovation and disruption. This year, Nexterday North will embrace the business culture of courage with the event’s theme: “Dare More. Be More.”

“Nexterday North 2016 focused on getting digital and communications service providers to stop thinking about their digital transformation strategies and actually start implementing them,” said Juhani Hintikka, CEO of Comptel. “This year, Nexterday North will urge attendees who have taken action to courageously go beyond that initial execution – to be more daring in their strategies and ultimately, be more than what the industry has come to expect.”

The three-day event will offer compelling keynote presentations from a diverse collection of innovative leaders and disrupters from all corners of the digital landscape, including executives from Deutsche Telekom, 2degrees Mobile, and Saudi Telecom.

Nexterday North’s roster of top-notch keynote speakers will feature Jason Silva, host of National Geographic Channel’s #1 rated and Emmy-nominated series, Brain Games; inspirational futurist Mark Stevenson; Hilary Mason, CEO and Founder of Fast Forward Labs, an independent data technology research lab; best-selling author Adam Alter; and Sarah Harrison of The Courage Foundation, an international organisation that protects whistleblowers and truth tellers.

Nexterday North’s three-day agenda will also feature:

  • Industry Blueprint Alley, a gallery of innovative and field-proven blueprints created by leading industry players, including Nokia/Comptel, Accenture, Salesforce and TCS. The alley is open to visitors throughout the event.
  • The Dare More. Be More. LIVE Digital debate features industry-leading analysts and business transformers, along with their customers, who will debate the two most critical aspects of digital transformation: perfecting the elusive digital experience and how to make it happen! Join Accenture, TCS, Salesforce, Avanto Ventures and Analysys Mason for two lively and LIVE debates.
  • Plenty of activity in form of the Nexterday run, Happy Hour, tasty food by Richard McCormick, live entertainment and the Nexterday app allowing you network and meet up with your peers

Resources

  • Find out more about Nexterday North, including its agenda and speakers. Register to attend at nexterdaynorth.com.
  • For press and analysts that would like to register for Nexterday North, please contact comptel@marchcomms.com.
  • Download a free copy of the latest Nexterday book, and visit Nexterday.org for more content from and for digital and communications business leaders.

About Nexterday North
Nexterday North is the annual “anti-seminar” that brings together movers and shakers from the digital and communications industry to share cross-industry foresights, insights and inspirational stories on digital transformation to empower innovation and disruption. Through interactive demos, industry blueprints and roundtable discussions, Nexterday North is where leaders from around the world converge to navigate digital transformation challenges and push the boundaries of the digital communications industry further. For more information, visit: www.nexterdaynorth.com.

4th Annual INTERACT User Community Event brings Ricoh customers together to collaborate on the future of production inkjet printing

Users from around the world gather in Boulder, Colorado, to learn from, interact and share ideas with peers and Ricoh inkjet and workflow experts

MALVERN, Pa., Aug. 24, 2017 /PRNewswire/ — Ricoh today announced the success of its fourth annual INTERACT Users Community Event, an established community gathering built on trusted partnerships. Its value is rooted in attendees’ underlying belief that the best way to empower digital workplaces is to establish a collaborative community and a sense of partnership with those involved in the daily processes of using Ricoh’s solutions. The 2017 event centered on collaboration, education and information sharing with an overarching focus on helping customers leverage technologies that enable them to reach a desired business result.

This highly acclaimed event promoted actionable and effective information sharing via tracks focused on production inkjet business development, production inkjet education and workflow best practices while also showcasing Ricoh’s latest technological advancements, business best practices and industry trends. The speaker lineup boasted industry thought leaders and conversation provokers including Pat McGrew, Director and Evangelist, Production Workflow Service of Keypoint Intelligence; Brent Niemuth, President and Chief Creative Officer of J. Schmid & Associates; Timothy D. Cooper, Enterprise Architect of Harland Clarke Holdings Company; and Christian Haneke, head of technical transformation at Druckhaus Haberbeck GmbH. These educational sessions took a deep look into the technologies and processes that are shaping the future of print and invited attendees to join the conversation regarding what comes next for Ricoh, their businesses and for the industry.

“The true power of intimate events like INTERACT is the wealth of information sharing, collaboration and education that occurs between peers and our Ricoh team,” said Jeff Paterra, Executive Vice President, Commercial & Industrial Printing Business Group, Ricoh Americas. “It’s a real two-way street. Without these insights, we cannot continue to deliver innovative solutions and promote industry advocacy that help our users work smarter and successfully deliver for their customers. And without the hands-on learning and networking with peers, users may not reap the full potential of their Ricoh services. It’s these conversations that truly make industry-changing innovation possible, and we’re looking forward to our next wave.”

As technology continues to drive change, being aware of the latest advances and the best ways to take advantage of them is increasingly important. INTERACT is based on the belief that the best way to address this need is to directly involve key industry stakeholders, both as a form of intelligence pooling and as a way to ensure strong feedback loops for businesses looking to keep up and get ahead.

Feedback was extremely positive from this year’s attendees, which included many returning companies and individuals who have found serious value in INTERACT. Highlights include:

  • “I was honored to be invited to join Ricoh and its customers at INTERACT. Immediately, I felt it was best mix of technical education, market education, motivation and fun for the attendees,” said Pat McGrew, Director, Production Workflow Service, Keypoint Intelligence/InfoTrends. “Ricoh is known for its industry advocacy and customer partnerships, and it was really powerful to see it in action.”
  • “INTERACT is a truly unique event. I attended last year, and I came again because it’s a great way for us to not only share our ideas for how Ricoh can better work with us, but also to learn from our American colleagues in the industry. The markets in Germany and the United States are different, but there are also many similarities, and it’s interesting to share our experiences and learn from fellow users,” said Christian Haneke, head of technical transformation at Druckhaus Haberbeck GmbH.
  • “The idea that I could share my experience with someone entering the field is really, really valuable to me. I greatly value mentorship, and I think it’s absolutely vital in this industry. I remember, after one of the sessions I spoke for, someone came up and asked me, ‘Why were you so open with your secrets in a room full of competitors?’ But the fact is, at a conference like this, they’re not my competitors. We’re all on the same team, because growth for our peers is growth for the industry. If I’m sharing the secrets that I’ve used to make Ironmark successful, that’s helping elevate the whole industry. If they get to our level, and we feel the heat from the competition, that just means we have to keep pushing harder to create a new level,” said Lynne Kingsley, Vice President, Marketing & Strategic Services, Ironmark.

As the pioneer in the continuous feed inkjet industry, Ricoh continues to make investments in its market growth to help the community uncover ways to streamline workflows, drive efficiencies and produce effective output.

To learn more about the Ricoh INTERACT User Community Events and how to participate in the 2018 INTERACT Event, please contact your local Ricoh representative.

For details on Ricoh’s full line of products, services and solutions for the production print market, please visit www.ricoh-usa.com or www.TakeALookAtRicoh.com. Also, follow @RicohProPrint on Twitter, Ricoh USA Production Print on LinkedIn and Ricoh USA Production Print on Facebook.

| About Ricoh |

Ricoh is empowering digital workplaces using innovative technologies and services enabling individuals to work smarter. For more than 80 years, Ricoh has been driving innovation and is a leading provider of document management solutions, IT services, commercial and industrial printing, digital cameras, and industrial systems.

Headquartered in Tokyo, Ricoh Group operates in approximately 200 countries and regions. In the financial year ended March 2017, Ricoh Group had worldwide sales of 2,028 billion yen (approx. 18.2 billion USD).

For further information, please visit www.ricoh.com.

© 2017 Ricoh USA, Inc. All rights reserved. All referenced product names
are the trademarks of their respective companies.

Contacts:
John Greco
Ricoh USA, Inc.
(973) 882-2023
john.greco@ricoh-usa.com

Tracey Sheehy
Breakaway Communications
(212) 616-6003
tsheehy@breakawaycom.com

View original content with multimedia:http://www.prnewswire.com/news-releases/4th-annual-interact-user-community-event-brings-ricoh-customers-together-to-collaborate-on-the-future-of-production-inkjet-printing-300509150.html

SOURCE Ricoh USA, Inc.

Real-World Data From Surveillance Study At 12 Months Confirms Excellent Safety And Tolerability Profile Of New, Non-Prescription FDgard® For Functional Dyspepsia

– Functional Dyspepsia Safety Update at 12 months (FDSU-12) reported no serious adverse events for FDgard® among the estimated 392,554 patients who used the product- FDSU-12 reconfirms the excellent safety profile seen in FDSU-6- FDgard® is a recently introduced and clinically studied, non-prescription medical food specially formulated for the dietary management of Functional Dyspepsia (FD)- Functional Dyspepsia, known for its symptoms of persistent or recurring indigestion with no known organic cause, impacts an estimated 1 in 6 adults in the U.S.

BOCA RATON, Fla., Aug. 24, 2017 /PRNewswire/ — IM HealthScience® (IMH) today announced favorable results from its Functional Dyspepsia Safety Update at 12 months (FDSU-12), a real-world, post-marketing surveillance study reporting on the safety and tolerability profile of FDgard® among an estimated 392,554 patients who used the product. The results found no serious adverse events. Additionally, the rates and patterns of non-serious adverse events were low (0.014 percent or 57 people out of 392,554 patients studied) and generally consistent with those normal adverse events commonly associated with an FD population. These non-serious adverse events included dyspepsia, rash, headache and abdominal pain.

The FDSU-12 captured and analyzed serious and non-serious adverse event reports for FDgard® over a twelve-month period from July 8, 2016, to July 8, 2017.

FDgard® is a non-prescription medical food specially formulated for the dietary management of Functional Dyspepsia (FD). FD is often characterized as persistent or recurring indigestion with no known organic cause.  Gastrointestinal symptoms can include epigastric pain or discomfort, inability to finish a normal-sized meal, heaviness, pressure, nausea, bloating and belching.  Currently, there are no approved drugs for FD and off-label medications are used to treat the condition.  

“Functional dyspepsia can have a significant impact on one’s quality of life,” said Michael S. Epstein, M.D., F.A.C.G., A.G.A.F., a leading gastroenterologist and Chief Medical Advisor for IM HealthScience®. “The findings from FDSU-12 reaffirm the safety and tolerability profile of FDgard® in real-world settings and are very reassuring. FDgard® is an effective and well-tolerated option in the management of patients with FD where few options are available.”

About FDSU-12
The Functional Dyspepsia Safety Update at 12 months (FDSU-12) is a real-world, post-marketing surveillance study reporting on the safety and tolerability profile of FDgard® among an estimated 392,554 patients who used the product. An independent call center was retained with pharmacovigilance-trained health care personnel in accordance with U.S. Food and Drug Administration (FDA) and global regulatory guidelines on properly reporting events and to receive and record FDgard® customer questions, product issues and adverse events. The adverse events for this study were collected and processed from July 8, 2016, to July 8, 2017. An analysis of data by reviewers showed that there were no serious adverse events associated with the use of FDgard® during this time frame. Only 57 patients reported non-serious adverse events, out of an estimated 392,554 patients who used FDgard® during this period. The adverse event rate of 0.014 percent was low and the reviewers believed it was difficult to separate these adverse events from the normal adverse events commonly associated with an FD population. In fact, dyspepsia was the most reported non-serious adverse event which is the underlying condition being treated for in this patient population taking FDgard®.

About Functional Dyspepsia (FD)
Approximately 30 percent of adults suffer from dyspepsia and about half are estimated to have FD or non-ulcer dyspepsia.1This condition can have a negative effect on workplace attendance and productivity, with associated costs estimated in excess of $18 billion annually.2

In FD, the normal digestive processes are disrupted along with the digestion and absorption of food nutrients. FD is accompanied by symptoms, such as epigastric pain or discomfort, postprandial fullness, abdominal heaviness and pressure, early satiation, bloating in the upper abdomen, nausea and belching. When doctors diagnose FD, they often identify patients as follows: patients should have these symptoms for at least three months with symptom onset six months previously.

About FDgard® 
FDgard® is a non-prescription medical food designed to address an unmet medical need for products to help in managing FD and its accompanying symptoms.  FDgard® capsules contain caraway oil and l-Menthol, the primary component in peppermint oil, for the dietary management of Functional Dyspepsia (FD). With its patented Site Specific Targeting (SST®) technology, pioneered by IM HealthScience®, FDgard® capsules release individually triple-coated, solid-state microspheres of caraway oil and l-Menthol quickly and reliably where they are needed most in FD — the upper belly. The l-Menthol helps with smooth muscle relaxation and caraway oil helps mitigate the effect of gastric acid on the stomach wall and also helps to normalize gallbladder function as well as deliver promotility and analgesic action in the small intestine (the duodenum) and the stomach.3 4 5 In addition to caraway oil and l-Menthol, FDgard® also provides fiber and amino acids (from gelatin protein). These ingredients have additional positive effect on the gut wall and this helps toward normalizing digestion and absorption.

Caraway oil and peppermint oil have a history of working in FD. In multiple clinical studies, the combination of caraway oil and peppermint oil has been shown to manage FD and its accompanying symptoms, such as reducing the intensity of epigastric pain, pain frequency, dyspeptic discomfort and reducing the intensity of sensations of pressure, abdominal heaviness and fullness…significantly better than placebo. Targeted delivery to the upper belly is desirable and now, with SST®, this has now become possible.

Data from the landmark, multi-centered, post-marketing, parallel group, U.S-based study, entitled FDREST™ (Functional Dyspepsia Reduction and Evaluation Safety Trial), showed that patients with FD who received FDgard® versus a control arm of placebo plus commonly used, off-label FD medications experienced a statistically significant reduction in Postprandial Distress Syndrome (PDS) symptoms (early satiety, abdominal  heaviness, pressure and fullness) and near statistical significance in Epigastric Pain Syndrome (EPS) symptoms (epigastric pain or discomfort and burning) at 24 hours. In spite of the polypharmacy and use of rescue medications for FD after 48 hours of first dose, FDgard® helped further improve symptoms at 4 weeks.

Specifically, the FDREST™ study showed that at 24 hours, FDgard® improved FD symptoms in patients and provided rapid and significant reduction in EPS and PDS symptoms in the PDS sub-group as well as a statistically significant reduction in EPS and PDS symptoms in the EPS sub-group. At 4 weeks, approximately 75 percent of the EPS and PDS patients in the FDgard® arm had substantial symptom (clinical global) improvement vs. approximately half in the control arm6.

There were no serious adverse events in the FDREST™ clinical study.

About IM HealthScience®
IM HealthScience® (IMH) is the innovator of IBgard® and FDgard® for the dietary management of Irritable Bowel Syndrome (IBS) and Functional Dyspepsia (FD), respectively. It is a privately held company based in Boca Raton, Florida. It was founded in 2010 by a team of highly experienced pharmaceutical research and development and management executives. The company is dedicated to developing products to address gastrointestinal issues where there is a high unmet need. The IM HealthScience® advantage comes from developing products based on its patented, targeted-delivery technologies called Site Specific Targeting (SST®). For more information, visit www.imhealthscience.com to learn about the company, or www.IBgard.com or www.FDgard.com.

1 Copyright © 1997 International Foundation for Functional Gastrointestinal Disorders (IFFGD). All rights reserved. Functional Dyspepsia and IBS: Incidence and Characteristics.

2 Lacy, B.E., Weiser, K.T., Kennedy, A.T., Crowell, M.D., & Talley, N.J. (2013). Functional dyspepsia: the economic impact to patients. Alimentary Pharmacology & Therapeutics, 38:170-177. doi: 10.111/apt.12355.

3 Shams, R., Oldfield, E.C., Copare, J., & Johnson, D.A. (2015). Peppermint Oil: Clinical Uses in the Treatment of Gastrointestinal Diseases. JSM Gastroenterology and Hepatology, 3 (1): 1035-1046.  

4 Sun, J. (2007). D-Limonene: Safety & Clinical Applications. Alternative Medicine Review, 12 (3): 259-264.

5 Goncalves, J.C.R., Alves, A. de Miranda H., de Araujo, A.E.V., Cruz, J.S., & Araujo, D.A.M. (2010). Distinct effects of carvone analogues on the isolated nerve of rats. European Journal of Pharmacology, 645:108-112. doi: 10.1016/j.ejphar.2010.07.027.

6 Chey, W.D., Lacy, B.E., Cash, B.D., Epstein, M.S., & Shah, S. (2017, May). Efficacy of Caraway Oil/L-Menthol Plus Usual Care vs Placebo Plus Usual Care, in Functional Dyspepsia Patients with Post-Prandial Distress (PDS) or Epigastric Pain (EPS) Syndromes: Results from a US RCT. Poster session presented at the Digestive Disease Week meeting, the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery, Chicago, IL.

View original content:http://www.prnewswire.com/news-releases/real-world-data-from-surveillance-study-at-12-months-confirms-excellent-safety-and-tolerability-profile-of-new-non-prescription-fdgard-for-functional-dyspepsia-300508841.html

SOURCE IM HealthScience

Black Coffee 2017 Global Key Players – Starbucks, UCC, Pacific Coffee, Chameleon, Craftsman of Coffee, Kohana Coffee Market Analysis and Forecast to 2022

Wiseguyreports.Com adds “Black Coffee Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

Report Details:

The report provides in depth study of “Black Coffee Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Black Coffee Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies Black Coffee in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

Global Black Coffee market competition by top manufacturers/players, with Black Coffee sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player, covering

This report focuses on the top players in global market, like
Starbucks(US)
UCC(Japan)
Pacific Coffee(HK)
Chameleon(US)
Craftsman of Coffee(US)
Kohana Coffee(US)
Califia Farms(US)
High Brew(US)
Volcanica Coffee(US)
Royal Kona(US) 

This report has a complete understanding of market value and quantity, technological progress, macro-economic and governmental policy based on past and present data along with the current and upcoming trends in the market.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1924786-global-black-coffee-sales-market-report-2017

Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Black Coffee for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

 On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Dark Roast Coffee
Black Instant Coffee
Black Silk Coffee
Black Iced Coffee
Black Ground Coffee
Organo Gold Black Coffee
On the basis on the end users/applications,
this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Black Coffee for each application, including
Drink To Go
Supermarkets Service
Convenience Stores Service
Personal Use

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/1924786-global-black-coffee-sales-market-report-2017

Major Key Points in Table of Content:

Global Black Coffee Sales Market Report 2017
1 Black Coffee Market Overview
1.1 Product Overview and Scope of Black Coffee
1.2 Classification of Black Coffee by Product Category
1.2.1 Global Black Coffee Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Black Coffee Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Dark Roast Coffee
1.2.4 Black Instant Coffee
1.2.5 Black Silk Coffee
1.2.6 Black Iced Coffee
1.2.7 Black Ground Coffee
1.2.8 Organo Gold Black Coffee
1.3 Global Black Coffee Market by Application/End Users
1.3.1 Global Black Coffee Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Drink To Go
1.3.3 Supermarkets Service
1.3.4 Convenience Stores Service
1.3.5 Personal Use
1.4 Global Black Coffee Market by Region
1.4.1 Global Black Coffee Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Black Coffee Status and Prospect (2012-2022)
1.4.3 China Black Coffee Status and Prospect (2012-2022)
1.4.4 Europe Black Coffee Status and Prospect (2012-2022)
1.4.5 Japan Black Coffee Status and Prospect (2012-2022)
1.4.6 Southeast Asia Black Coffee Status and Prospect (2012-2022)
1.4.7 India Black Coffee Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Black Coffee (2012-2022)
1.5.1 Global Black Coffee Sales and Growth Rate (2012-2022)
1.5.2 Global Black Coffee Revenue and Growth Rate (2012-2022)

….

9 Global Black Coffee Players/Suppliers Profiles and Sales Data
9.1 Starbucks(US)
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Black Coffee Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Starbucks(US) Black Coffee Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 UCC(Japan)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Black Coffee Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 UCC(Japan) Black Coffee Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Pacific Coffee(HK)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Black Coffee Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Pacific Coffee(HK) Black Coffee Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Chameleon(US)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Black Coffee Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Chameleon(US) Black Coffee Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Craftsman of Coffee(US)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Black Coffee Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Craftsman of Coffee(US) Black Coffee Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Kohana Coffee(US)
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Black Coffee Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Kohana Coffee(US) Black Coffee Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Califia Farms(US)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Black Coffee Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Califia Farms(US) Black Coffee Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 High Brew(US)
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Black Coffee Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 High Brew(US) Black Coffee Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Volcanica Coffee(US)
9.10 Royal Kona(US)

Continued….

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1924786

Contact Us:

NORAH TRENT               

Ph: +1-646-845-9349 (US)

Sales@Wiseguyreports.Com

Ph: +44 208 133 9349 (UK)

EMEA (Europe, Middle East and Africa) Bone Void Filler Market by Region, Production, Consumption, Revenue, Market Share and Growth Rate to 2022

MarketResearchNest.com adds “EMEA (Europe, Middle East and Africa) Bone Void Filler Market Report 2017” new report to its research database. The report spread across 119   pages with multiple tables and figures in it.

 

This report studies the EMEA (Europe, Middle East and Africa) Bone Void Filler market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the EMEA (Europe, Middle East and Africa) Bone Void Filler market by product type and applications/end industries.

The global EMEA (Europe, Middle East and Africa) Bone Void Filler market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Browse full table of contents and data tables at https://www.marketresearchnest.com/emea-europe-middle-east-and-africa-bone-void-filler-market-report-2017.html

Major players in the market are identified through secondary research and their market revenues determined through primary and secondary research. The major players in global EMEA (Europe, Middle East and Africa) Bone Void Filler market include

Synthes, BoneSupport, Heraeus Medica, Osteotech, Wright Medical, SBM (Science for BioMaterials),
Zimmer, MedicalBiomat, Stryker, Graftys?, Integra LifeSciences.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of EMEA (Europe, Middle East and Africa) Bone Void Filler in these regions, from 2012 to 2022 (forecast), covering

Europe, Middle East, Africa.

 

Global EMEA (Europe, Middle East and Africa) Bone Void Filler Market Sales (K Units) and Revenue (Million USD) Market Split by Regions

Market Segment by Region  2017 2018 2019 2020 2021 2022
Europe XX XX XX XX XX XX
Middle East XX XX XX XX XX XX
Africa XX XX XX XX XX XX
Total XX (%) XX (%) XX (%) XX (%) XX (%) XX (%)

Order a Purchase Report Copy @ https://www.marketresearchnest.com/purchase.php?reportid=253787

On the basis of product, the EMEA (Europe, Middle East and Africa) Bone Void Filler market is primarily split into
Hydroxyapatite, Tricalcium phosphate (TCP), Calcium sulfate, Others.

Global EMEA (Europe, Middle East and Africa) Bone Void Filler Market Sales (K Units) and Revenue (Million USD) Market Split by Product Type

Market Segment by Type 2016 2017 2018 2019 2020 2021 2022
Hydroxyapatite xx xx xx xx xx xx xx
-Change (%) xx% xx% xx% xx% xx% xx% xx%
Tricalcium phosphate (TCP) xx xx xx xx xx xx xx
-Change (%) xx% xx% xx% xx% xx% xx% xx%
Calcium sulfate xx xx xx xx xx xx xx
-Change (%) xx% xx% xx% xx% xx% xx% xx%
Others xx xx xx xx xx xx xx
-Change (%) xx% xx% xx% xx% xx% xx% xx%
Total xx xx xx xx xx xx xx
-Change (%) xx% xx% xx% xx% xx% xx% xx%

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of EMEA (Europe, Middle East and Africa) Bone Void Filler for each application, including:

Dental, Skeleton, Others.

Global EMEA (Europe, Middle East and Africa) Bone Void Filler Market Sales (K Units) and Revenue (Million USD) Market Split by end users

 Market Segment by End Users/Applications 2012 2016 2022 Market Share (%)2022 CAGR
(2016-2022)
Dental xx xx xx xx% xx%
Skeleton xx xx xx xx% xx%
Others xx xx xx xx% xx%
Total xx xx xx XX% xx%

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast.

Request a sample copy at

https://www.marketresearchnest.com/requestsample.php?reportid=253787

 

About Us:

MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.

Contact Us

Mr. Jeet Jain

Sales Manager

sales@marketresearchnest.com

+1-240-284-8070(U.S)

+44-20-3290-4151(U.K)

Connect with us:  Google+ | LinkedIn | Twitter | Facebook

Safety Air Bags Sales Market 2017, Size Trends and Forecasts to 2022

“The Global Safety Air Bags Sales  Market Report includes a comprehensive analysis of the present of the market. The report starts with the basic Safety Air Bags Sales  industry overview and then goes into each and every detail.”

 

Description

The Global Safety Air Bags Sales  Industry report provides key information about the industry, including invaluable facts and figures, expert opinions, and the latest developments across the globe. The Report also calculate the market size, the report considers the revenue generated from the sales of This Report and technologies by various application segments.

Secondly the study, besides estimating the Safety Air Bags Sales ‘ market potential till 2022, analyzes on who can be the market leaders and what partnerships would help them to capture the market share. The report gives an overview about the dynamics of the market, by discussing various aspects such as drivers, restraints, Porter’s 5 forces, value chain, customer acceptance and investment scenario

Access Safety Air Bags Sales  Global Market Report at:  https://www.marketreportsworld.com/10461598

Following are the Major Key Players of Safety Air Bags Sales  Market:

Autoliv
TRW
Key Safety Systems
Toyoda Gosei
Nihon Plast
Yanfeng Automotive Trim Systems
East JoyLong Motor Airbag
Hyundai Mobis
BYD
S&T Motiv
Jinheng Automotive Safety Technology Hoidings

Get a Sample of Global Safety Air Bags Sales  Market Research Report at:

https://www.marketreportsworld.com/enquiry/request-sample/10461598

Major Topics Covered in Safety Air Bags Sales  Industry Research Report are as follows:

Marketing Strategy Analysis, Distributors/Traders

  • Marketing Channel
  • Direct Marketing
  • Indirect Marketing
  • Marketing Channel Development Trend included in SAFETY AIR BAGS SALES industry
  • Market Positioning
  • Pricing Strategy
  • Brand Strategy of SAFETY AIR BAGS SALES market
  • Target Client
  • Distributors/Traders List

Market Effect Factors Analysis

  • Technology Progress/Risk
  • Substitutes Threat
  • Technology Progress in SAFETY AIR BAGS SALES Industry
  • Consumer Needs/Customer Preference Change
  • Economic/Political Environmental Change

 Global Safety Air Bags Sales  Market Forecast 2017-2022

  • Global Safety Air Bags Sales Capacity, Production, Revenue Forecast 2017-2022
  • Global Safety Air Bags Sales Production, Consumption Forecast by Regions 2017-2022
  • Global Safety Air Bags Sales Production Forecast by Type 2017-2022
  • Global Safety Air Bags Sales Consumption Forecast by Application 2017-2022
  • Safety Air Bags Sales Price Forecast 2017-2022

Get Global Safety Air Bags Sales  Market Research Purchase Report at: https://www.marketreportsworld.com/purchase/10461598

Lastly In this Safety Air Bags Sales  Market analysis, traders and distributors analysis is given along with contact details. For material and equipment suppliers also, contact details are given. New investment feasibility analysis is included in the report.

The report covers the market landscape and its growth prospects over the coming years, the Report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market shares.

Key Points Covered in TOC:

Global Safety Air Bags Sales  Market Research Report 2017

Global Safety Air Bags Sales  Market Competition by Manufacturers

Global Safety Air Bags Sales  Capacity, Production, Revenue (Value) by Region (2012-2017)

Global Safety Air Bags Sales  Supply (Production), Consumption, Export, Import by Region (2012-2017)

Global Safety Air Bags Sales  Production, Revenue (Value), Price Trend by Type

Global Safety Air Bags Sales  Market Analysis by Application

Global Safety Air Bags Sales  Manufacturers Profiles/Analysis

Safety Air Bags Sales  Manufacturing Cost Analysis

Industrial Chain, Sourcing Strategy and Downstream Buyers

Marketing Strategy Analysis, Distributors/Traders

Market Effect Factors Analysis

Global Safety Air Bags Sales  Market Forecast (2017-2022)

Mechanical Actuators Market In-depth Analysis, Business Growth, Technology, Applications and R&D Landscape 2017-2021

The Mechanical Actuators Market report covers the present scenario and the growth prospects of the Mechanical Actuators Market for 2017-2021. The capability of these actuators to handle heavy loads and their easy maintenance are the primary factors that will have a positive influence on the growth of this market

Global Mechanical Actuators market to grow at a CAGR of 2.10% during the period 2017-2021.

The report provides a basic overview of the Mechanical Actuators Market including definitions, classifications, applications and market Sales chain structure. The Mechanical Actuators Market report enlists several important factors, starting from the basics to advanced market intelligence which play a crucial part in strategizing.

Get a PDF Sample of Mechanical Actuators Market Research Report at: http://www.absolutereports.com/enquiry/request-sample/11113163

Mechanical Actuators Market Opportunities:

With a purpose of enlightening new entrants about the possibilities in this market, this report investigates new project feasibility. Various details about the manufacturing process such as market drivers, impact of drivers, market challenges and impact of drivers and challenges, market trends, vendor landscape analysis and so on, is discussed in the report.

Key Players in Mechanical Actuators Market 2017-2021:

  • Tolomatic
  • TiMOTION
  • Warner Linear
  • Sonceboz
  • Aerotech
  • Thomson
  • Physik Instrumente (PI)
  • Others

Other Prominent Vendors:

  • Duff-Norton
  • Emerson
  • Moog
  • Rotork
  • Val-Matic

Complete Details Report with List of Figures, Tables and Charts Available @: https://www.absolutereports.com/global-mechanical-actuators-market-2017-2021-11113163

The Mechanical Actuators Market Is Divided into The Following Segments Based On Geography:

  • Americas
  • APAC
  • EMEA

In the end, the report makes some important proposals for a new project of Mechanical Actuators Market Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2017-2021 global Mechanical Actuators Market industry covering all important parameters.

Mechanical Actuators Market Driver:

  • Low cost of mechanical actuators
  • For a full, detailed list, view our report

Mechanical Actuators Market Challenge:

  • Automation is not supported by mechanical actuators
  • For a full, detailed list, view our report

Mechanical Actuators Market Trend:

  • Growing use of ball screws in mechanical actuators
  • For a full, detailed list, view our report

Have Any Query? Ask Our Expert @ http://www.absolutereports.com/enquiry/pre-order-enquiry/11113163

Key Questions Answered in This Mechanical Actuators Market Report:

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Access This Report @ http://www.absolutereports.com/purchase/11113163

List of Exhibit of Global Mechanical Actuators Market 2017-2021

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?

And Continue…

Get offer on Mechanical Actuators Market Research Report at: http://www.absolutereports.com/enquiry/request-discount/11113163

About Absolute Report:

Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market dedicated towards bringing you an ingenious concoction of data parameters.

Contact:

Mr. Ameya Pingaley

Absolute Reports

+1-408 520 9750

Email: sales@absolutereports.com

已发表的临床数据显示,Nuwiq®对既往未曾治疗的患者免疫原性低、有效性卓著

瑞士拉亨–(BUSINESS WIRE)–(美国商业资讯) — Octapharma欣然宣布,NuProtect研究(GENA-05, NCT01712438)的中期数据已经发表:Nuwiq®治疗既往未曾治疗的患者(PUP)的首批临床数据于2017年8月16日作为预览论著发表于国际著名的医学杂志《血友病》(Haemophilia)。

NuProtect研究启动于2013年3月,旨在研究Nuwiq® 对重症血友病A PUP的免疫原性、有效性和安全性,此类患者形成抑制因子的风险最大。此项进行中的研究已入组110 PUP,不论年龄或种族,均接受Nuwiq®最多达100个暴露日(ED),因而成为样本量最大的单一FVIII制品研究之一。研究排除既往接受过FVIII浓缩物或含FVIII的血制品的患者。

这篇最新发表的论著描述了66例PUP的中期结果,他们均治疗至少20个ED,多数抑制因子都是在这个时间形成的。所有抑制因子的累积发生率(95%可信区间)为20.8% (10.7–31.0),高滴度抑制因子为12.8% (4.5–21.2)。研究显示,Nuwiq®预防出血的有效性卓著,自发出血的中位年出血率为0,所有出血为2.40。Nuwiq®还能有效治疗出血(92.4%的出血经1或2次输注即可控制),并能预防手术出血(89%的外科手术中评级为“卓著”或“良好”)。上述中期结果证实了Nuwiq® 对经治患者卓著的止血有效性。

血液病国际业务部负责人Larisa Belyanskaya表示:“研究结果令我们感到振奋,我们同时感到高兴的是,上述中期数据现在能够发表于《血友病》这样的专科同行评议杂志,这是人类细胞生产的rFVIII治疗PUP的首次研究报告数据,上述结果将Nuwiq®与市面上的其他产品进一步区分开来。

Octapharma AG董事Olaf Walter补充表示:“上述数据显示,Nuwiq®PUP的免疫原性低,PUP形成抑制因子的风险最大,研究还证实了经治患者中观察到的Nuwiq®的卓著有效性。Octapharma的目标是让凝血障碍患者能够正常生活,此次发表是迈向这一目标过程中的又一重要步骤。

Octapharma要感谢参与研究的所有人,特别是患者和家属,没有他们,这项研究就不可能完成。

关于NuProtect (GENA-05)研究

NuProtect临床研究(NCT01712438)是3期、开放、干预性临床研究,在38家中心开展,评估至少100例既往未曾治疗的患者(PUP),这些患者均为重症血友病A,包括所有年龄和族裔,入组研究最多达100个暴露日(ED)或最长5年。排除既往接受过FVIII浓缩物/含FVIII的血制品的患者。主要目的是在中心实验室采用Nijmegen改良贝塞斯达检测,确定抑制因子的活性,从而评估Nuwiq®的免疫原性。NuProtect研究的最终数据预计于2019年出炉。欲了解该试验的进一步信息,请访问:www.clinicaltrials.gov。延伸研究(GENA-15, NCT01992549)将进一步评估Nuwiq® 对PUP的长期免疫原性、有效性和安全性。

关于Nuwiq®

Nuwiq®是第四代rFVIII蛋白质1,在人类细胞中生产,未经化学修饰或任何蛋白质融合2。Nuwiq®的培养不含人源性或动物源性添加物2,不含非人类蛋白质抗原决定簇3,平均半衰期为17.1小时4,5,与von Willebrand凝血因子的亲和力高6。已完成7项评估Nuwiq®治疗的临床试验,涉及201例重症血友病A PTP 7,8(190人),其中包含59例儿童9。Nuwiq®在欧盟、美国、加拿大、澳大利亚、拉丁美洲和俄罗斯获准用于治疗和预防所有年龄组血友病A PTP的出血。Nuwiq®正计划在世界其他国家报批。

参考文献:

1. FDA Nuwiq® memorandum (STN 125555), 9 October 2014(FDA Nuwiq® 备忘录(STN 125555), 2014年10月9日).

2. Casademunt E, et al. Eur J Haematol 2012; 89: 165-76.(《欧洲血液学杂志》2012; 89: 165-76.)

3. Kannicht C, et al. Thromb Res. 2013;131:78-88.(《血栓形成研究》2013;131:78-88.)

4. Nuwiq® European Public Assessment Report, 22 May 2014.(Nuwiq®欧洲公开评估报告,2014年5月22日。)

5. NUWIQ® US Prescribing Information, September 2015.(NUWIQ®美国处方信息,2015年9月。)

6. Sandberg H, et al. Thromb Res 2012; 130: 808-17.(《血栓形成研究》2012; 130: 808-17.)

7. Valentino LA, et al. Haemophilia 2014; 20(Suppl. 1): 1-9(《血友病》2014;20(增刊1):1-9)

8. Lissitchkov T, et al. Haemophilia 2017; e-pub ahead of print; doi: 10.1111/hae.13251(《血友病》2017;纸质版付印前电子版;doi: 10.1111/hae.13251)

9. Klukowska A, et al. Haemophilia 2016; 22, 232-39. (《血友病》2016; 22, 232-39.)

关于血友病A

血友病A是FVIII缺乏所致的X染色体连锁遗传疾病,如果未加治疗,可导致肌肉和关节出血,继而导致关节病和重度病损。FVIII替代预防性治疗可减少出血发作次数和永久性关节损伤的风险。该病在全球的患病率为每5,000至10,000名男性中有一例。全球75%的血友病病例未获诊断或治疗。患者体内产生针对输入性FVIII的中和抗体(FVIII抑制因子),是最严重的治疗并发症。据报道,目前发生FVIII抑制因子的累积风险可高达39%。

关于Octapharma

Octapharma总部位于瑞士拉亨,是世界上最大的人类蛋白质制造商之一,致力于开发、生产源于人体血浆和人体细胞系的人类蛋白质。作为一家家族企业,Octapharma致力于切实改善人们的生活质量,而且自1983年以来便一直从事这一行业;因为这是我们与生俱来的使命。

2016年,公司实现了16亿欧元的营收,3.83亿欧元的运营收入,并投资了2.49亿欧元用于确保公司未来的发展。Octapharma在全球雇用了7,100多名员工,用以下三大领域的产品为113个国家病患的治疗提供支持:

  • 血液科(凝血障碍)
  • 免疫疗法(免疫障碍)
  • 重症监护

Octapharma在奥地利、法国、德国、墨西哥和瑞典拥有六处一流的生产设施。

垂询详情,请访问www.octapharma.com

免责声明:本公告之原文版本乃官方授权版本。译文仅供方便了解之用,烦请参照原文,原文版本乃唯一具法律效力之版本。

Green Pepper Market is Anticipated to Grow US$ 486 Mn by 2022

Global production of green pepper has been steadily expanding over the past couple of years due to its growing application in the food and beverage sector. Compared to white and black pepper, green pepper has a lower penetration. Green pepper is usually available in either brine or vinegar mixture that prevents it from getting spoiled. However, pure form of green pepper is also popularlhttps://www.factmr.com/connectus/sample?flag=D&rep_id=94y consumed in many countries. The product is used as a natural preservative in various processed food items and is rich in potassium, vitamin-C, iron, manganese and dietary fibers. In addition, green pepper has antioxidant properties – making it popular among consumers who seek to maintain a healthy diet.  Green pepper is also beneficial in treating as well as preventing cancer, liver, and cardiovascular diseases. Moreover, increasing demand for exotic hot cuisines and rare green pepper variants is projected to positively impact the green pepper sales in the near future. According to the latest report published by Fact.MR, the global market for green pepper will expand at little under 4% CAGR during 2017 and 2022 to reach a valuation of around US$ 486.6 Mn.

Following points from Fact.MR’s global market for green pepper forecast will be crucial for market’s future prospects

  • On the basis of form, the ground green pepper segment is expected to remain dominant throughout the assessment period. Currently, this segments holds close to 40% market share in terms of revenue. Over US$ 200 Mn worth ground green pepper is likely to be sold worldwide. Between 2017 and 2022, the segment is anticipated register an above average CAGR.

A sample of this report is available upon request @www.factmr.com/connectus/sample?flag=S&rep_id=94

  • Among regions, Europe will continue to be the most lucrative market for green pepper during the forecast period. The region currently commands for the largest revenue share of the global market. The market is projected to increase at close to 5% CAGR over the next five years.
  • Demand for organic green pepper will be relatively higher as compared to the conventional variant during the forecast period. Rising preference for organic products and growing consumer awareness about health benefits of organic ingredients is boosting the demand for organic green pepper.

Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=94

  • In recent years, application of green pepper has expanded exponentially across industries. The Fact.MR report mentions the food and beverage application segment will continue to command for the dominant share of the market over 2022.  In addition, the food & beverage segment currently accounts for around 27% revenue share of the market.
  • On the basis of distribution channels, the modern trade segment is expected to surpass a market valuation of US$ 176 Mn over 2022. Currently, the segment accounts for over 35 % revenue share of the market.

Competition Tracking

Key players mentioned in Fact.MR’s report include Associated British Foods (Ach), Beidahuang Group, Bunge Limited, Fuji Vegetable Oil, Inc., Ach Food Companies, Inc., Marico Limited, Ruchi Soya Industries Ltd, The Adani Wilmar Ltd., Archer Daniels Midland Company, Cargill, Inc., ConAgra Foods (Agrotech Foods Ltd), Olympic Oils Limited, Borges Mediterranean Group, Adams Group, and American Vegetable Oils, Inc.

Click to view complete report @ www.factmr.com/report/94/green-pepper-market

About Us

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

Office: Dublin 2

Suite 9884

27 Upper Pembroke Street,

Dublin 2, Ireland

Tel: +353-1-6111-593

( Dublin 2 )

Email: sales@factmr.com

Web: https://www.factmr.com